http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
( Jiyoul Yang ),( Sang-bum Hong ),( Chae-man Lim ),( Younsuck Koh ),( Jin Won Huh ) 대한결핵 및 호흡기학회 2021 대한결핵 및 호흡기학회 추계학술대회 초록집 Vol.129 No.-
Introduction In Korea, the Physician Orders for Life-Sustaining Treatment (POLST) has been implemented since 2018, for the refusal of meaningless life-prolonging treatment and a death with dignity. The purpose of this study is to investigate how the POLST is actually applied to patients with cancer who have been admitted to the intensive care unit (ICU). Method The medical records of patients who received POLST among cancer patients admitted to the medical ICU from February 2018 to June 2020 were retrospectively reviewed. Result A total of 1049 cancer patients were admitted to the medical ICU, 604 of those patients who received POLST were included during this study period. Among them, 29 patients (4.8%) received POLST before admission to the ICU, and 575 patients (95.2%) obtained POLST after admission to the ICU. The average time from the assessment for the patient at the End Stage of Life to the verification of Decision of patient or patient family was about 0.54 days and the assessment and verification was done on the same day in 583 patients (96.5%). The decision on Life-Sustaining Treatment (LST) plan were done by the patient’s family in 466 patients (77.2%). Only 138 patients (22.8%) self-determined the LST plan. In the 142 patients (23.5%), POLST was received within 48 hours after the admission to the ICU. Three-hundred forty-four patients (60.0%) were transfer to the ward after clinical improvement and 87 surviving patients (14.4%) were discharged. Conclusion Even after the implementation of POLST, the Decision on the LST plan were done by the patients’ family in most cases. About half of the patients who received POLST were transferred to the ward after advanced intensive care. There still seems to be a gap between the LST decision system and the medical environment.
( Junghwa Chung ),( Gawon Ju ),( Jiyoul Yang ),( Jiwon Jeong ),( Yusook Jeong ),( Moon Ki Choi ),( Jihyun Kwon ),( Ki Hyeong Lee ),( Seung Taik Kim ),( Hye Sook Han ) 대한내과학회 2018 The Korean Journal of Internal Medicine Vol.33 No.3
Background/Aims: The purpose of the present study was to assess the prevalence of and factors associated with anxiety and depression in Korean patients with advanced gastrointestinal cancer. Methods: One hundred and twenty consecutive patients with newly diagnosed, advanced gastrointestinal cancer who were scheduled to receive palliative chemotherapy between July 2012 and June 2014 were enrolled in this observational prospective study. Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire-9 (PHQ-9). Results: Thirty-seven patients (30.8%) had anxiety or depression with clinical significance according to HADS or PHQ-9. Multivariate analysis identified lower performance status (odds ratio [OR], 4.19; 95% confidence interval [CI], 1.22 to 14.35; p = 0.023), gastric cancer (OR, 5.39; 95% CI, 0.37 to 78.23; p = 0.018), and knowledge of advanced cancer (OR, 15.07; 95% CI, 1.80 to 125.90; p = 0.012) as significantly associated with anxiety or depression. Twenty-one patients with anxiety or depression visited the psycho-oncologic clinic. In these patients, PHQ-9 score (p = 0.008), global health status (p = 0.023), fatigue (p = 0.047), and appetite loss (p = 0.006) improved from baseline to 3 months after study enrollment. Conclusions: Approximately 30% of Korean patients with advanced gastrointestinal cancer had anxiety or depression. The prevalence of anxiety or depression was higher in patients with poor performance status, gastric cancer, or knowledge of advanced cancer. Psychiatric interventions may be effective in reducing depression and improving quality of life in cancer patients with anxiety or depression.